======= VCPIP1 ======= == Gene Information == * **Official Symbol**: VCPIP1 * **Official Name**: valosin containing protein interacting protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80124|80124]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96JH7|Q96JH7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VCPIP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VCPIP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611745|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a deubiquitinating enzyme. Necessary for VCP- mediated reassembly of Golgi stacks after mitosis. May play a role in VCP-mediated formation of transitional endoplasmic reticulum (tER). Mediates dissociation of the ternary complex containing STX5A, NSFL1C and VCP (By similarity). Hydrolyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitin chains. {ECO:0000250, ECO:0000269|PubMed:23827681}. |OTU| |endoplasmic reticulum membrane fusion| |Golgi reassembly| |protein K11-linked deubiquitination| |Golgi inheritance| |organelle inheritance| |protein K48-linked deubiquitination| |Golgi stack| |organelle membrane fusion| |organelle fusion| |thiol-dependent ubiquitin-specific protease activity| |membrane fusion| |Golgi organization| |protein deubiquitination| |protein modification by small protein removal| |endoplasmic reticulum lumen| |endomembrane system organization| |mitotic cell cycle| |protein ubiquitination| |protein modification by small protein conjugation| |membrane organization| |protein modification by small protein conjugation or removal| |proteolysis| |cell cycle| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-2.19| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-2.14| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-2.02| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.97| |[[:results:exp332|Adefovir 20μM R07 exp332]]|-1.96| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-1.85| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.83| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.76| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.73| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.78| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.87| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.05| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.3| ^Gene^Correlation^ |[[:human genes:o:otud5|OTUD5]]|0.536| |[[:human genes:u:ubr5|UBR5]]|0.487| |[[:human genes:k:kcmf1|KCMF1]]|0.476| |[[:human genes:u:ube2l3|UBE2L3]]|0.466| |[[:human genes:m:mllt1|MLLT1]]|0.445| |[[:human genes:b:brpf1|BRPF1]]|0.433| |[[:human genes:m:meaf6|MEAF6]]|0.426| |[[:human genes:c:ccdc101|CCDC101]]|0.426| |[[:human genes:m:med13l|MED13L]]|0.424| |[[:human genes:d:dnajc3|DNAJC3]]|0.416| |[[:human genes:h:hhex|HHEX]]|0.416| |[[:human genes:t:thoc6|THOC6]]|0.407| |[[:human genes:p:polr3h|POLR3H]]|0.402| Global Fraction of Cell Lines Where Essential: 8/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|2/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|2/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5018 * **Expression level (log2 read counts)**: 6.02 {{:chemogenomics:nalm6 dist.png?nolink |}}